Rentokil Initial (LON:RTO – Get Free Report) had its price target dropped by equities researchers at Citigroup from GBX 575 to GBX 550 in a report issued on Friday,London Stock Exchange reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 56.96% from the stock’s previous close.
Several other analysts also recently weighed in on RTO. Royal Bank Of Canada reissued an “outperform” rating and issued a GBX 540 price target on shares of Rentokil Initial in a research note on Friday, June 5th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 550 price objective on shares of Rentokil Initial in a research note on Thursday, July 9th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 468.33.
View Our Latest Analysis on Rentokil Initial
Rentokil Initial Trading Down 0.5%
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
Recommended Stories
- Five stocks we like better than Rentokil Initial
- Peeling Out or Breaking Down? Ford’s High-Stakes Turnaround
- Generac’s AI Power Story Is Becoming Bigger Than the Weather
- Everyone’s Focused on China—But That’s Not ASML’s Biggest Risk
- Chipotle Mexican Grill Stock Rallies as Q2 Results Top Fears, Guidance Rises
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
